Authors
Keval Raval, Alkeshkumar Patel, Pravin Tirgar
Published in
Medical oncology (Northwood, London, England). Volume 43. Issue 12. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
Protein tyrosine phosphatase 1B (PTP1B) promotes breast cancer progression through oncogenic signaling. p-propoxybenzoic acid (p-PBA) is a phytoconstituent with reported anti-proliferative and anti-mitotic activity, potentially mediated through PTP1B inhibition. Therefore, p-PBA was hypothesized to exert an ameliorative effect against 7,12-dimethylbenz(α)anthracene (DMBA)-induced breast cancer through PTP1B inhibition. Forty-eight rats were divided into six groups. Excluding the normal control group, all animals received DMBA (50 mg/kg; subcutaneously) for tumor induction. Three groups received p-PBA (50, 100, or 150 mg/kg/day) orally for 20 weeks, including 2 weeks of pretreatment. The standard control group received tamoxifen (4 mg/kg; intraperitoneally) twice weekly for 20 weeks. Tumor onset was monitored for 20 weeks. At Week 20, morphological changes were examined. Subsequently, tumor volume (TV), tumor weight (TW), blood glucose levels (BGLs), blood parameters, oxidative biomarkers, hepatic injury biomarkers, and pro-inflammatory cytokines were evaluated. PTP non-receptor 1 (PTPN1) expression was evaluated through gene expression analysis and histopathology of tumor tissues was performed to assess the protective effects of p-PBA. p-PBA significantly delayed tumor onset and reduced the morphological damage. P-PBA treatment significantly reduced TV, TW, and BGLs. The p-PBA (100 mg/kg) and p-PBA (150 mg/kg) groups significantly regulated the levels of blood parameters. p-PBA significantly modulated oxidative biomarkers, hepatic injury biomarkers, and pro-inflammatory cytokines. Gene expression analysis indicated a significant PTPN1 downregulation in p-PBA-treated animals. Histopathological analysis revealed a protective effect of p-PBA in preventing the progression of breast cancer. p-PBA exhibited an ameliorative effect on DMBA-induced breast cancer, potentially through PTP1B inhibition.
PMID:
43002335
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0